INDIGENOUS AND MULTINATIONAL PHARMACEUTICAL COMPANIES

被引：0

|

作者：

LILJA, J ^{[1
]}

机构：

[1] UNIV KUOPIO,DEPT SOCIAL PHARM,SF-70101 KUOPIO 10,FINLAND

来源：

SOCIAL SCIENCE & MEDICINE | 1983年 / 17卷 / 16期

关键词：

D O I：

10.1016/0277-9536(83)90009-6

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

收藏

页码：1171 / 1180

页数：10

相关论文

共 50 条

[21] Effect of Patent Expiry on the Performance of Innovator Multinational Pharmaceutical Companies in a Low Middle Income Country
Khalil, Farrukh
Onyango, Joseph Odhiambo
FRONTIERS IN MEDICAL TECHNOLOGY, 2022, 4
[22] Internationalisation of pharmaceutical R&D: how globalised are Europe's largest multinational companies?
Tijssen, Robert J. W.
TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT, 2009, 21 (07) : 859 - 879
[23] New Protectionism and multinational companies
SannaRandaccio, F
JOURNAL OF INTERNATIONAL ECONOMICS, 1996, 41 (1-2) : 29 - 51
[24] Multinational companies and environmental issues
McLaren, D
INTERNATIONAL BUSINESS: ADJUSTING TO NEW CHALLENGES AND OPPORTUNITIES, 2002, : 31 - 36
[25] MULTICULTURAL MANAGEMENT IN MULTINATIONAL COMPANIES
Reslova, Martina
HRADECKE EKONOMICKE DNY 2014: EKONOMICKY ROZVOJ A MANAGEMENT REGIONU, DIL III, 2014, : 33 - 39
[26] INTRODUCTION TO STUDY OF MULTINATIONAL COMPANIES
BROWAEYS, X
ANNALES DE GEOGRAPHIE, 1974, 83 (456): : 141 - 172
[27] MULTINATIONAL COMPANIES AND THIRD WORLD
TURNER, L
WORLD TODAY, 1974, 30 (09): : 394 - 402
[28] SPATIAL STRATEGIES OF MULTINATIONAL COMPANIES
HANAPPE, P
METRA, 1974, 13 (01): : 17 - 31
[29] MULTINATIONAL COMPANIES AND NATIONAL WELFARE
DEMEZA, D
AUSTRALIAN ECONOMIC PAPERS, 1983, 22 (41) : 491 - 494
[30] PROCUREMENT STANDARDS OF MULTINATIONAL COMPANIES
Ribic, Damir
Oremus, Ivona
7TH INTERNATIONAL SCIENTIFIC SYMPOSIUM ECONOMY OF EASTERN CROATIA - VISION AND GROWTH, 2018, : 602 - 618

← 1 2 3 4 5 →